The Benzinga Cannabis team is out on tour, reporting on big developments in the cannabis world.
Managing Director Javier Hasse will be in Denver, Colorado this week for the NCIA's Cannabis Caucus.
Javier will then be at Avicanna’s second annual symposium, The Emergence of Biopharmaceutical Cannabinoids – From Research & Development to Clinical Translation, in Toronto on March 25. Javier will be speaking on the panel “Canada’s Leadership Position in the Emerging Global Industry,” alongside Avicanna’s Aras Azadian, BMO Capital Markets’ Michael Astone, Prohibition Partners’ Stephen Murphy and CannTrust's Kaivan Talachian.
Also in Toronto that week will be Benzinga Cannabis staff writer Andrew Ward.
For Europe-related issues, contact Alex Oleinic.
The Benzinga Cannabis team is always traveling. Shoot us a message any time to find out when they will hit your city next.
For news tips and pitches, please email editorial@benzinga.com
And make sure to get your tickets for the Cannabis Capital Conference in Toronto, April 17-18, following this link.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
